JPS60136514A - 抗炎症抗潰瘍性組成物 - Google Patents

抗炎症抗潰瘍性組成物

Info

Publication number
JPS60136514A
JPS60136514A JP59253903A JP25390384A JPS60136514A JP S60136514 A JPS60136514 A JP S60136514A JP 59253903 A JP59253903 A JP 59253903A JP 25390384 A JP25390384 A JP 25390384A JP S60136514 A JPS60136514 A JP S60136514A
Authority
JP
Japan
Prior art keywords
glycyrrhetinic acid
theophylline
sodium
administered
carbenoxolone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59253903A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0333126B2 (xx
Inventor
ビアトリス・ヤツクーチヤーン・ワン
ポール・ユアキン・サクラ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biorex Laboratories Ltd
Original Assignee
Biorex Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Laboratories Ltd filed Critical Biorex Laboratories Ltd
Publication of JPS60136514A publication Critical patent/JPS60136514A/ja
Publication of JPH0333126B2 publication Critical patent/JPH0333126B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP59253903A 1983-12-02 1984-11-29 抗炎症抗潰瘍性組成物 Granted JPS60136514A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB83.32265 1983-12-02
GB838332265A GB8332265D0 (en) 1983-12-02 1983-12-02 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
JPS60136514A true JPS60136514A (ja) 1985-07-20
JPH0333126B2 JPH0333126B2 (xx) 1991-05-16

Family

ID=10552750

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59253903A Granted JPS60136514A (ja) 1983-12-02 1984-11-29 抗炎症抗潰瘍性組成物

Country Status (4)

Country Link
JP (1) JPS60136514A (xx)
DE (1) DE3443858A1 (xx)
FR (1) FR2555899B1 (xx)
GB (2) GB8332265D0 (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62164650A (ja) * 1986-01-17 1987-07-21 Maruzen Kasei Kk グリチルレチン酸誘導体およびこれを含有する抗潰瘍剤

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6984667B2 (en) * 1998-04-08 2006-01-10 Theta Biomedical Consulting And Development Co. Synergistic proteoglycan compositions for inflammatory conditions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62164650A (ja) * 1986-01-17 1987-07-21 Maruzen Kasei Kk グリチルレチン酸誘導体およびこれを含有する抗潰瘍剤

Also Published As

Publication number Publication date
DE3443858A1 (de) 1985-06-13
GB2150435B (en) 1986-10-15
GB2150435A (en) 1985-07-03
GB8428710D0 (en) 1984-12-27
FR2555899A1 (fr) 1985-06-07
FR2555899B1 (fr) 1988-10-14
GB8332265D0 (en) 1984-01-11
JPH0333126B2 (xx) 1991-05-16

Similar Documents

Publication Publication Date Title
US5206029A (en) Medicament and its production and use in the treatment of pain, inflammation and fever in man and animals
JP3041232B2 (ja) 癌転移抑制剤
KR940011244B1 (ko) 신장 질환 치료제
JP2002532543A (ja) 抗アテローム硬化剤としてのプロアントシアニジンａ２リン脂質複合体
US4814353A (en) Therapeutic and prophylactic agent for gastritis
JPS60136514A (ja) 抗炎症抗潰瘍性組成物
JP3877807B2 (ja) 口内炎治療・予防剤
JPH11507921A (ja) 新規な医薬用途
US4447437A (en) Pharmaceutical composition and method for treatment of peptic ulcer
JP2812998B2 (ja) 胃炎治療剤
JP2681085B2 (ja) 胃炎治療剤
RU2675237C1 (ru) Соединение (6-{ [(1S)-1(5-фтор-4-оксо-3-фенил-3,4-дигидрохиназолин-2-ил)пропил]амино} -9Н-пурин-9-ил)метилацетат как ингибитор p110δ - дельта-изоформы фосфоинозитид-3-киназы (PI3K), способы его получения (варианты) и применения
JPS5938206B2 (ja) 補酵素ｑを主成分とする気管支喘息治療剤
CA2684171C (fr) Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo-4-pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes craniens
JP2804445B2 (ja) 胃潰瘍および十二指腸潰瘍の処置剤および抗炎症剤
JPS643168B2 (xx)
JPH0959158A (ja) ベンズイミダゾール誘導体を含有するぜん息治療剤
EP0308349B1 (fr) Nouveau derivé de choline, son procédé de préparation et nouveaux médicaments le contenant
CN113398109A (zh) 一种预防或治疗炎性肠病的酮体混合物及其应用
JPS58118514A (ja) 活性成分としてコラン酸誘導体を含む胆汁分泌物質活性治療用組成物
JPH03294226A (ja) 非ステロイド抗炎症剤により生じる胃疾患の予防用医薬組成物
JPS634806B2 (xx)
JPS62185016A (ja) アセチルサリチル酸マグネシウム−尿素錯化合物含有医薬および該医薬の製造方法
JPH0466530A (ja) ３―オキシゲルミルプロピオン酸作用安定化錠剤及び該錠剤の組成物を主成分とする風邪症侯群治療剤
JPS59106419A (ja) 消化器の炎症および潰瘍の治療剤